(Q35011152)

English

Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Panasiuk Anatol

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Flisiak Robert

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Prokopowicz Danuta

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

language of work or name

0 references

publication date

1 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

World Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1854-1858

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Cell adhesion regulates platelet-derived growth factor-induced MAP kinase and PI-3 kinase activation in stellate cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305890

8 July 2018

Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305890

8 July 2018

Mechanism of action of ribavirin in the combination treatment of chronic HCV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305890

8 July 2018

Integral role of the EGF receptor in HGF-mediated hepatocyte proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305890

8 July 2018

The kinetics of hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305890

8 July 2018

Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305890

8 July 2018

Hepatitis C virus protein expression induces apoptosis in HepG2 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305890

8 July 2018

Epidermal growth factor reduces multiorgan failure induced by thioacetamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305890

8 July 2018

Hepatitis C virus and its pathogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305890

8 July 2018

Expression of epidermal growth factor and its receptor in cirrhotic liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305890

8 July 2018

Hepatocyte growth factor/scatter factor enhances the thrombopoietin mRNA expression in rat hepatocytes and cirrhotic rat livers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305890

8 July 2018

Platelets and inflammation: role of platelet-derived growth factor, adhesion molecules and histamine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305890

8 July 2018

Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305890

8 July 2018

Classification of chronic viral hepatitis: a need for reassessment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305890

8 July 2018

Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305890

8 July 2018

Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I12.1854

21 January 2018

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I12.1854

21 January 2018

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I12.1854

21 January 2018

A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I12.1854

21 January 2018

Detection of serum and intrahepatic human hepatocyte growth factor in patients with type C liver diseases

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I12.1854

21 January 2018

Improved conditions to induce hepatocytes from rat bone marrow cells in culture

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I12.1854

21 January 2018

Expression of platelet-derived growth factor-BB in liver tissues of patients with chronic hepatitis B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305890

25 October 2018

Serum hepatocyte growth factor levels in liver diseases: clinical implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/15793880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additivity of the proliferative effects of HGF/SF and EGF on hepatocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15793880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/15793880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15793880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocyte growth factor in patients with three different stages of chronic liver disease including hepatocellular carcinoma, cirrhosis and chronic hepatitis: an immunohistochemical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15793880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High serum hepatocyte growth factor levels in the acute stage of community-acquired infectious diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/15793880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantification of hepatic thrombopoietin mRNA transcripts in patients with chronic liver diseases shows maintained gene expression in different etiologies of liver cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15793880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced plasma transforming growth factor-beta1 levels in patients with chronic hepatitis C after interferon-alpha therapy: association with regression of hepatic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15793880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3748/WJG.V11.I12.1854

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35011152&oldid=1952956670"